Loading clinical trials...
Loading clinical trials...
International Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial Evaluating Efficacy and Safety Of BCD-100 in Combination With Pemetrexed+Cisplatin/Carboplatin Compared to Placebo in Combination With Pemetrexed+Cisplatin/Carboplatin as First-Line Treatment of Subjects With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Conditions
Interventions
BCD-100
Pemetrexed
+2 more
Locations
37
Czechia
Regional Hospital Liberec
Liberec, Czechia
University Hospital Olomouc
Olomouc, Czechia
University Hospital Ostrava
Ostrava, Czechia
Multiscan Pardubice - Radiology Center
Pardubice, Czechia
High technology Hospital Medcenter
Batumi, Georgia
Acad. F.Todua Medical center "Research institute of Clinical Medicine"
Tbilisi, Georgia
Start Date
June 1, 2019
Primary Completion Date
December 1, 2023
Completion Date
December 1, 2023
Last Updated
September 17, 2020
Lead Sponsor
Biocad
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions